X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs UNICHEM LAB - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA UNICHEM LAB FULFORD INDIA/
UNICHEM LAB
 
P/E (TTM) x 398.8 21.8 1,826.0% View Chart
P/BV x 6.2 2.3 270.3% View Chart
Dividend Yield % 0.1 0.8 10.2%  

Financials

 FULFORD INDIA   UNICHEM LAB
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
UNICHEM LAB
Mar-16
FULFORD INDIA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs942334 282.0%   
Low Rs450174 258.6%   
Sales per share (Unadj.) Rs691.4146.9 470.6%  
Earnings per share (Unadj.) Rs11.511.9 96.4%  
Cash flow per share (Unadj.) Rs15.416.2 94.9%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.30.8 36.5%  
Book value per share (Unadj.) Rs380.0105.1 361.5%  
Shares outstanding (eoy) m3.9090.84 4.3%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.01.7 58.2%   
Avg P/E ratio x60.721.4 284.3%  
P/CF ratio (eoy) x45.315.7 288.8%  
Price / Book Value ratio x1.82.4 75.8%  
Dividend payout %17.416.8 103.8%   
Avg Mkt Cap Rs m2,71423,073 11.8%   
No. of employees `0000.45.7 7.8%   
Total wages/salary Rs m5052,558 19.7%   
Avg. sales/employee Rs Th6,073.02,352.5 258.2%   
Avg. wages/employee Rs Th1,137.4450.9 252.2%   
Avg. net profit/employee Rs Th100.7190.4 52.9%   
INCOME DATA
Net Sales Rs m2,69613,346 20.2%  
Other income Rs m125192 65.3%   
Total revenues Rs m2,82213,538 20.8%   
Gross profit Rs m-461,639 -2.8%  
Depreciation Rs m15390 3.9%   
Interest Rs m1029 33.0%   
Profit before tax Rs m541,412 3.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-4 0.0%   
Extraordinary Inc (Exp) Rs m0-35 0.0%   
Tax Rs m10293 3.3%   
Profit after tax Rs m451,080 4.1%  
Gross profit margin %-1.712.3 -14.0%  
Effective tax rate %17.720.7 85.3%   
Net profit margin %1.78.1 20.5%  
BALANCE SHEET DATA
Current assets Rs m1,7385,979 29.1%   
Current liabilities Rs m5452,432 22.4%   
Net working cap to sales %44.326.6 166.5%  
Current ratio x3.22.5 129.8%  
Inventory Days Days4863 76.8%  
Debtors Days Days460 7.1%  
Net fixed assets Rs m126,403 0.2%   
Share capital Rs m39182 21.5%   
"Free" reserves Rs m1,4439,293 15.5%   
Net worth Rs m1,4829,548 15.5%   
Long term debt Rs m0230 0.0%   
Total assets Rs m2,07712,843 16.2%  
Interest coverage x6.750.0 13.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.31.0 125.0%   
Return on assets %2.68.6 30.2%  
Return on equity %3.011.3 26.7%  
Return on capital %4.314.3 30.0%  
Exports to sales %029.2 0.0%   
Imports to sales %24.56.3 385.4%   
Exports (fob) Rs mNA3,900 0.0%   
Imports (cif) Rs m659847 77.9%   
Fx inflow Rs m174,356 0.4%   
Fx outflow Rs m6731,162 57.9%   
Net fx Rs m-6563,194 -20.5%   
CASH FLOW
From Operations Rs m901,119 8.0%  
From Investments Rs m105-853 -12.3%  
From Financial Activity Rs m-14-334 4.2%  
Net Cashflow Rs m181-68 -264.3%  

Share Holding

Indian Promoters % 0.0 50.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 15.1 25.2%  
FIIs % 0.1 3.0 3.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 31.7 66.9%  
Shareholders   4,783 20,176 23.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   NOVARTIS  ASTRAZENECA PHARMA  STRIDES SHASUN LTD  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare FULFORD INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - STERLING BIOTECH COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS